Facebook Linkedin RSS Twitter Youtube
Home 2024

Ovarian cancer

StockWatch: Wall Street’s Leaders and Laggards of 2024
GEN Edge

StockWatch: Wall Street’s Leaders and Laggards of 2024

Eczema Drugs Could Counter Ovarian Cancer’s IL-4-Based Immunotherapy Resistance
Cancer

Eczema Drugs Could Counter Ovarian Cancer’s IL-4-Based Immunotherapy Resistance

Ovarian Cancer: Early Detection with AI-Aided Biomarker Analysis
Cancer

Ovarian Cancer: Early Detection with AI-Aided Biomarker Analysis

Breast, Ovarian Cancer Risks of RAD51C Variants Assessed with Saturation Genome Editing
Cancer

Breast, Ovarian Cancer Risks of RAD51C Variants Assessed with Saturation Genome Editing

StockWatch: Cognition Stays the Course as Shares Plunge on Alzheimer’s Data
Drug Discovery

StockWatch: Cognition Stays the Course as Shares Plunge on Alzheimer’s Data

Using Multiplexed Multi-Omics to Study Spatial Heterogeneity in Ovarian Cancer
Cancer

Using Multiplexed Multi-Omics to Study Spatial Heterogeneity in Ovarian Cancer

3D-Printed Tumors Replicate Biopsies of Cancer Patients
Cancer

3D-Printed Tumors Replicate Biopsies of Cancer Patients

Insilico Joins Scramble to Treat Solid Tumors by Targeting KIF18A
Artificial Intelligence

Insilico Joins Scramble to Treat Solid Tumors by Targeting KIF18A

Drugs, Dollars, and Data: Recursion Eyes Cost Savings from AI Drug Discovery
Artificial Intelligence

Drugs, Dollars, and Data: Recursion Eyes Cost Savings from AI Drug Discovery

Cancer Drug Discovery May Accelerate as Many Overlooked Targets Prioritized
Cancer

Cancer Drug Discovery May Accelerate as Many Overlooked Targets Prioritized

123...29Page 1 of 29
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.